CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease
- 31 May 2008
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (5) , 669-675
- https://doi.org/10.1016/j.neurobiolaging.2006.11.018
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairmentNeurobiology of Aging, 2006
- Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentNeurobiology of Aging, 2005
- Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric studyJournal of Neurology, Neurosurgery & Psychiatry, 2005
- MRI and CSF studies in the early diagnosis of Alzheimer's diseaseJournal of Internal Medicine, 2004
- Cerebrospinal Fluid Tau and β-AmyloidArchives of Neurology, 2003
- CSF markers for incipient Alzheimer's diseaseThe Lancet Neurology, 2003
- The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's diseaseNeuroscience, 1999
- Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer DiseaseArchives of Neurology, 1999
- Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”Neurobiology of Aging, 1998
- The Mini-Mental State ExaminationArchives of General Psychiatry, 1983